Endo International PLC (NASDAQ:ENDP)
| 2.75 Delayed Data As of Sep 20 |  -0.09 / -3.18%Today’s Change | 1.94 Today|||52-Week Range 10.89 | -61.70% Year-to-Date |
Latest ENDP News | Press Releases
| Endo (ENDP) Gains on Settlement of Opioid Cases in New York for $50M Sep 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.83 |
| Today’s open | 2.72 |
| Day’s range | 2.63 - 2.76 |
| Volume | 5,668,316 |
| Average volume (3 months) | 8,775,475 |
| Market cap | $658.5M |
Data as of 5:01pm ET, 09/20/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -19.33% |
| Earnings growth (next 5 years) | +4.60% |
| Revenue growth (last year) | -0.39% |
| P/E ratio | 5.9 |
| Price/Sales | 0.58 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GTHXG1 Therapeutics Inc | -0.45 | -2.89% |
| CLLSCellectis SA | -0.93 | -6.44% |
| ORMPOramed Pharmaceutica... | -1.33 | -6.49% |
| ---- |
Data as of 4:00pm ET, 09/20/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | $0.46 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | $183.9M |
| Net profit margin | 8.52% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
